Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Actos Equity
Mandate

Vinge advises Actos Equity

March 18, 2017 M&A

MyDentist is a new dentist chain that wants to change the conservative dentistry industry through a clearly-defined concept which offers improved dental care in an easily accessible, simple and attractive way.

Arctos Equity Partner is directly investing in the entrepreneur led company as an active long term partner.

Vinge advised Arctos Equity in connection with the investment in MyDentist AB. Vinge’s team consisted of Magnus Pauli, Natalie Bäck, Petronella Hallberg and Camilla Andersson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026